Latest news

eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST

eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity

eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months

World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge

Dr. Paul Opgenorth

eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing

Chris Marlett, MDB Capital

Slack Capital interview: Chris Marlett, Chairman of the Board

Slack Capital interview: Damien Perriman, CCO

Michael Heltzen & Erum Azeez Khan

Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'

Tyler Korman

Slack Capital interview: Tyler Korman, VP of Research

Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update